Daiichi Sankyo to pay $39M to settle DOJ claims it paid kickbacks to docs

Japanese drugmaker Daiichi Sankyo will pay $39 million to state and federal health programs, and a whistleblower, to settle claims it paid doctors kickbacks to prescribe some of its drugs, Reuters reports. The settlement, the Justice Department said, stemmed from a whistleblower lawsuit filed by former Daiichi sales representative Kathy Fragoules. She will get $6.1 million of the settlement. The drugmaker was accused of enticing doctors with speaking fees and lavish dinners, sometimes to speak only to their own staffs, the government contended. Story

Suggested Articles

In an era of limited access to key decision makers, how are you mobilizing your field force to communicate the value of your brands and real-world evidence?

Novo Nordisk’s Ozempic is off to a blazing start, and the company just threw more fuel on the fire with a pair of trial wins.

Biosims to Roche's Big 3 cancer drugs will chisel out a $10 billion sales gap by 2023, but newer meds could chip in $16.3 billion, the drugmaker says.